High-Dose Tramadol in Comparison to Low-Dose Morphine for Cancer Pain Relief
- 1 September 1999
- journal article
- research article
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 18 (3) , 174-179
- https://doi.org/10.1016/s0885-3924(99)00060-3
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Dextropropoxyphene versus morphine in Opioid-Naive cancer patients with painJournal of Pain and Symptom Management, 1998
- Ten years of World Health Organization guidelines—Do they really work?Current Opinion In Anesthesiology, 1997
- A Risk-Benefit Assessment of Tramadol in the Management of PainDrug Safety, 1996
- Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective studyPain, 1995
- A regional survey of opioid use by patients receiving specialist palliative carePalliative Medicine, 1995
- Efficacy and safety of nonsteroidal antiinflammatory drugs for cancer pain: a meta-analysis.Journal of Clinical Oncology, 1994
- WHO stufe II—Klinische Realität oder didaktisches Instrument?Der Schmerz, 1994
- Oral tramadol, a μ-opioid agonist and monoamine reuptake-blocker, and morphine for strong cancer-related painAnnals of Oncology, 1994
- Tramadol hydrochloride in the relief of cancer pain. A double blind comparison against sustained release morphinePain, 1990
- A validation study of the WHO method for cancer pain reliefCancer, 1987